01
The development
What happened, what is new, and what is actually established.
Committed in May 2020 at $12 billion for one plant; restated at $40 billion in December 2022, $65 billion in April 2024 and $165 billion in March 2025. The first plant entered high-volume production of 4-nanometre chips in the fourth quarter of 2024. What is established is that one facility was built and is producing, and that the headline figure is an accumulation of announcements rather than a budget.
- Record
- Announced May 15, 2020
- Record
- Stated for Phoenix, Maricopa County, Arizona
- Record
- Headline figure $165.00bn — Total planned United States investment as restated on 3 March 2025, aggregating four successive commitments. Not an amount spent, and not the value of any single facility.
02
The underlying structure
How the transaction, policy, market or system actually works.
Each expansion is a separate commitment layered on the last, so the headline records intent across a decade while a single facility carries the demonstrated capability. Federal support arrives against milestones, which places the public claim on output rather than on the announced total. The company retains the option not to build later phases.
03
The parties and incentives
Who participates, what each party seeks, and what leverage each holds.
4 parties established by evidence. TSMC Arizona Corporation, Taiwan Semiconductor Manufacturing Company, State of Arizona, United States Department of Commerce.
TSMC Arizona Corporation
Project vehicleArizona, United StatesThe United States vehicle that holds and operates the Arizona facilities.
- Contributes
- Operations
- Pursues
- Execution of the announced phases
- Leverage
- Not established
- Exposure
- Not established
Inferred from the vehicle's role, recorded as a reading.
Taiwan Semiconductor Manufacturing Company
CorporationTaiwanParent and technology provider. Supplies the process technology and the capital behind each announced phase.
- Contributes
- Capital · Process technology · Customer relationships
- Pursues
- Geographic diversification of leading-edge capacity · Proximity to United States customers
- Leverage
- Control over whether later phases are built, which no agreement compels.
- Exposure
- Not established
Stated by the company at announcement.
State of Arizona
GovernmentArizona, United StatesHost state, supplying site support and state incentives around a Phoenix cluster.
- Contributes
- Site support · State incentives
- Pursues
- A semiconductor cluster within the state
- Leverage
- Not established
- Exposure
- Not established
Inferred from the state's role in the siting, recorded as a reading.
United States Department of Commerce
Government agencyUnited StatesProvider of federal semiconductor awards against construction and production milestones.
- Contributes
- Grants
- Pursues
- Advanced manufacturing capacity on United States soil
- Leverage
- Not established
- Exposure
- Awards conditioned on milestones the recipient reports against.
Stated in the federal award programme.
04
The money, assets, rights and obligations
Who supplies capital, who owns what, who controls decisions, who bears risk, and who captures returns.
2 flows of capital and 0 ownership interests recorded.
What each instrument means for the public exposure
- Grant. Public money given without repayment. The public exposure is the full amount.
- Private capital. Capital from outside the public sector. It is not public expenditure.
The valuation benchmark
M&A Multiples Index · ExitValue.ai
The register does not classify this arrangement to a sub-vertical, so no benchmark is applied. No multiple is inferred from the figure it states, because a price without a comparable set establishes nothing about whether that price was ordinary.
No ownership interest or project asset has been established by the evidence held.
No commitment, risk allocation or return mechanism has been established by the evidence held.
05
The causal intelligence
Why the development is occurring, and which alternative explanations remain plausible.
Not established from the evidence held.
No causal mechanism has been established by the evidence held.
06
The strategic implication
What changes for the customer, the counterparties, or the relevant institutions.
For a customer, the relevant question is capability rather than headline: one Arizona plant on 4-nanometre is a real second source, while the packaging and leading-edge capacity that would matter most remain unbuilt. For a competitor or a government, the comparison to hold is cost per wafer against Taiwan, which no announcement discloses.
07
The comparative intelligence
Precedents, alternative structures, and what transfers to another context.
Not established from the evidence held.
A comparable is a precedent, not a forecast. The cases above share purpose, state, market or stated geography with this arrangement; none of that establishes how this one will end.
08
The forward view
Scenarios, triggers, leading indicators, deadlines and conditional consequences.
Not established from the evidence held.
No leading indicator has been established for this assessment.
09
The decision
Concrete priorities, options, negotiation points, and what would change the recommendation.
Not established from the evidence held.
No decision implication has been established for this transaction.
10
The evidence position
Traceable sources, material limitations, unresolved facts, and calibrated confidence.
Production start and process node are documented by the company and confirmed by the federal government. The expanded commitments are announcements. Cost per wafer, yield economics and the return on each phase are not established.
Unresolved questions
Each is the specific agreement, disclosure, valuation or term that would materially change the reading. They are stated rather than filled with estimated provisions.
What does a wafer cost to make in Arizona relative to Taiwan?
Whether the plant is a durable source or a subsidised hedge.
Which later phases have committed customer volume behind them?
Whether the $165 billion is a plan or a sequence of options.
Uncertainty in the record
- Confirmed in November 2024. The disbursement schedule, and the conditions attaching to later phases, are not established here.
- An aggregate of four separate announcements across a decade, not a budget for any one facility. Only the first plant is built.
Limitations
- This record holds the first facility's production and the sequence of announced commitments. It does not establish capital deployed per phase, cost per wafer, or which later phases will be built.
- An expansion reported after the date of this record is not included here.